Alnylam Pharmaceuticals
ALNY
#451
Rank
C$71.80 B
Marketcap
C$543.51
Share price
-4.35%
Change (1 day)
51.14%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company